The conference is intended for all stakeholders in research and innovation, including both holders and users of health data, as well as their advisors. These issues involve all relevant ecosystems and sectors: academics, entrepreneurs, healthcare institutions and professionals, industry leaders, government agencies, legal experts, and researchers—at the regional, national, and even European levels.

Five roundtables to help you prepare your strategic projects:

Roundtable No. 1: How does French law serve as a first step toward the necessary secondary use of health data? Comparative perspectives;

Roundtable No. 2: What are the key contributions of REEDS to enabling and securing new secondary uses of health data?

Roundtable No. 3: Which stakeholders? Governance and mechanisms for secondary use;

Roundtable No. 4: What are the potential benefits? Economic models, intellectual property, royalties, trade secrets, among others;

Roundtable No. 5: What technical and security solutions are needed to ensure the system’s effectiveness? Q&A sessions are scheduled at the end of each roundtable.

A detailed program is provided below. You can attend the roundtables in-person or remotely.